Suchergebnisse - "Chau, Ian"

PubPharm (33)

1

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study) : an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

2

Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02) : primary and updated analyses from a single-arm, phase 2 study

enthalten in: The Lancet. Oncology | 2023

von Van Cutsem, E. | di Bartolomeo, M. | Smyth, E. | +13

3

Safety and efficacy review of aflibercept for the treatment of metastatic colorectal cancer

enthalten in: Expert opinion on drug safety | 2022

von Lau, D. | Mencel, J. | Chau, I.

4

HER2 targeted therapy in colorectal cancer : New horizons

enthalten in: Cancer treatment reviews | 2022

von Suwaidan, A. | Lau, D. | Chau, I.

5

Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Lote, H. | Chau, I.

6

EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers

enthalten in: Gut | 2021

von Smyth, E. | Vlachogiannis, G. | Hedayat, S. | +30

7

Harnessing biomarkers of response to improve therapy selection in esophago-gastric adenocarcinoma

enthalten in: Pharmacogenomics | 2021

von Fong, C. | Chau, I.

8

Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Gordon, L. | Kaplan, J. | Popat, R. | +21

9

Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolution

enthalten in: Critical reviews in oncology/hematology | 2019

von Khan, K. | Valeri, N. | Dearman, C. | +5

10

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer : Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

enthalten in: Clinical colorectal cancer | 2019

von Riechelmann, R. | Srimuninnimit, V. | Bordonaro, R. | +19